(Press-News.org) July 17, 2012, Shenzhen, China – BGI, the world's largest genomics organization, announced today that it has successfully developed a new filtering tool, PDXomics, which performs accurate and specific classification of the mixed reads derived from the host and tumor xenografts. Through the full utilization of this robust tool, researchers could develop the specific patient-derived xenografts (PDX) and advance the oncology drug discovery, biomarker development and their future applications.
Xenograft models serve as an important tool for many areas of biomedical research, including oncology, immunology and HIV pathology. There has been a recent increase in the use of tumor-specific PDX engrafted into immune-compromised rodents such as the most common athymic nude or NOD/SCID mice for preclinical modelling. However, the progress has been greatly hampered by the contamination resulted from the inevitable mixing between the host and the xenografts.
Considering the high degree of homology between human and mouse genomes, it is very difficult to minimize the contamination by the present physical or biochemical techniques, such as conservative sectioning, cell sorting or laser capture micro-dissection. In an effort to address the problem, researchers from BGI developed a fast, accurate and specific tool to classify the xenograft-derived sequence read data.
Researchers evaluated the tool on genomic data from three pairs of xenografts and case-matched primary tumor samples. The sequence reads were directly mapped to a mixed reference-set that contains both of human genome and mouse genome. When classifying the reads located in the DNA collinear regions of human and mouse, the result showed that PDXomics could specifically filter mouse reads from the mixed reads as well as keep human's.
Currently, there are two major traditional methods for analyzing the reads: one is processing the reads set with human genome as a reference; the other is processing the reads set first with mouse genome as a reference, then removing the mapped reads and processing the remaining reads with human genome again. To evaluate the accuracy and quality of PDXomics, researchers compared the analysis results with the two traditional methods, and they found that the PDXomics could significantly reduce the false-positive rate (FPR) of identified single-nucleotide mutations, and improve the accuracy of variation detection.
Zonghui Peng, Director, DEPT. of Pharma & Biotech Cooperation, BGI, said, "Over the past two decades, the applications of PDX have made great impact on the development of translational medicine. With the rapid development of next-generation sequencing (NGS) technology, PDXomics will be a robust tool in the optimization and screening of xenograft models in the near future, with the benefits of fast turnaround time, low cost and high efficiency."
INFORMATION:
About BGI
BGI was founded in Beijing, China, in 1999 with the mission to become a premier scientific partner for the global research community. The goal of BGI is to make leading-edge genomic science highly accessible, which it achieves through its investment in infrastructure, leveraging the best available technology, economies of scale, and expert bioinformatics resources. BGI, and its affiliates, BGI Americas, headquartered in Cambridge, MA, and BGI Europe, headquartered in Copenhagen, Denmark, have established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, supporting a variety of disease, agricultural, environmental, and related applications.
BGI has a proven track record of excellence, delivering results with high efficiency and accuracy for innovative, high-profile research: research that has generated over 200 publications in top-tier journals such as Nature and Science. BGI's many accomplishments include: sequencing one percent of the human genome for the International Human Genome Project, contributing 10 percent to the International Human HapMap Project, carrying out research to combat SARS and German deadly E. coli, playing a key role in the Sino-British Chicken Genome Project, and completing the sequence of the rice genome, the silkworm genome, the first Asian diploid genome, the potato genome, and, more recently, have sequenced the human Gut Metagenome, and a significant proportion of the genomes for the1000 Genomes Project. For more information about BGI, please visit www.genomics.cn
Contact Information:
Zonghui Peng
Director, DEPT. of pharma&Biotech Cooperation
BGI
Pengzonghui@genomics.cn
www.genomics.cn
Bicheng Yang
Public Communication Officer
BGI
+86-755-82639701
yangbicheng@genomics.cn
www.genomics.cn
END
Finding renewable and economic sources of energy are one of the most important concerns for the continuation of the human species. New research, published in BioMed Central's open access journal Biotechnology for Biofuels, has produced a novel strain of yeast with improved xylose tolerance and metabolism, and consequently improved ethanol production.
Bioethanol is considered one of cleanest renewable replacements for fossil fuel. However using glucose from crops, such as sugar cane or starch crops, uses up resources which could otherwise be used to produce food. Xylose ...
CHAPEL HILL, N.C. – Silymarin or "milk thistle," a popular herbal dietary supplement that many people take for liver ailments, works no better than placebo in patients with chronic hepatitis C infection.
That's the conclusion of a multicenter clinical trial published in the July 18, 2012 issue of the Journal of the American Medical Association.
"Patients ask me about milk thistle all the time," said Michael W. Fried, MD, lead author of the study, a professor in the University of North Carolina School of Medicine and director of the UNC Liver Center.
"Now I can tell ...
Several types of job carried out by future fathers may be linked to an increased risk of birth defects in their babies, suggests research published online in Occupational and Environmental Medicine.
Previous research has linked certain occupations with a higher risk of birth defects in offspring. But it has tended to lump together very different types of defects and occupations, in order to achieve large sample sizes, with the attendant potential to skew the results, say the authors.
They base their findings on data from the ongoing US National Birth Defects Prevention ...
Workplace exposure to organic solvents is linked to several types of heart defects at birth, indicates research published online in Occupational and Environmental Medicine.
Organic solvents are widely used for dissolving or dispersing substances, such as fats, oils, and waxes, as well as in chemical manufacturing. They are found in paints, varnishes, adhesives, degreasing/cleaning agents, dyes, polymers, plastic, synthetic textiles, printing inks and agricultural products.
Most organic solvents are highly volatile and enter the body through the lungs, but can also ...
Adding vitamin B12 to standard hepatitis C virus (HCV) treatment significantly boosts the body's ability to keep the virus at bay, indicates a pilot study published online in the journal Gut.
The effects were particularly strong in patients whose infection was proving difficult to treat effectively, the findings showed.
Between 60% and 80% of those infected with the viral liver infection HCV will go on to develop chronic hepatitis, and roughly a third of them will progress to cirrhosis and terminal liver disease.
Standard treatment of interferon (peg IFN) and ribavarin ...
BUFFALO, N.Y. -- Inspired by nature, an international research team has created synthetic pores that mimic the activity of cellular ion channels, which play a vital role in human health by severely restricting the types of materials allowed to enter cells.
The pores the scientists built are permeable to potassium ions and water, but not to other ions such as sodium and lithium ions.
This kind of extreme selectivity, while prominent in nature, is unprecedented for a synthetic structure, said University at Buffalo chemistry professor Bing Gong, PhD, who led the study.
The ...
Researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of British Columbia have published important data in the Journal of the American Medical Association (JAMA) about the impact of a common drug therapy on the progression of multiple sclerosis for people with the relapsing‑remitting form of the disease.
The study, led by Drs. Helen Tremlett, Afsaneh Shirani, Joel Oger and others, shows no strong
evidence that a group of drugs, beta interferons (β-IFNs), prescribed to treat MS had a measurable
...
The researchers reflect on their work as well as how the U.S. system for funding research makes the United States a leader. "Because of the opportunities provided by federal research funding, we are developing a generation of scientists that has no competitor on planet Earth," says Erik Dutson, executive medical director of the Center for Advanced Surgical and Interventional Technology at the University of California, Los Angeles.
They also talk about the risks of decreased funding. "If you have a population of scientists that [don't] have the resources to train the ...
A study of teenage girls with eating disorders has shown that reduced essential fatty acid levels returned to normal once the girls increased their weight to a healthy level.
The research, published in the August issue of Acta Paediatrica, suggests that it is not necessary to give omega-3 polyunsaturated fatty acid supplements to adolescent girls with eating disorders.
"Essential fatty acid status is altered in eating disorders that result in weight loss" explains co-author Dr Ingemar Swenne from Uppsala University Children's Hospital. "This is important because ...
Researchers from the Hebrew University of Jerusalem and the Weizmann Institute of Science have developed a technique to cause apoptosis, or programmed cell death, that could lead to new approaches to treating cancer.
Apoptosis is an essential defense mechanism against the spread of abnormal cells such as cancer. It is a complex process that occurs through networks of proteins that interact with each other. Cancer cells usually avoid this process due to mutations in the genes that encode the relevant proteins. The result is that the cancer cells survive and take over while ...
